Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Non-Current Deffered Revenue (2020 - 2025)

Historic Non-Current Deffered Revenue for Tango Therapeutics (TNGX) over the last 6 years, with Q2 2025 value amounting to $30.4 million.

  • Tango Therapeutics' Non-Current Deffered Revenue fell 4408.97% to $30.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $30.4 million, marking a year-over-year decrease of 4408.97%. This contributed to the annual value of $44.8 million for FY2024, which is 3286.74% down from last year.
  • According to the latest figures from Q2 2025, Tango Therapeutics' Non-Current Deffered Revenue is $30.4 million, which was down 4408.97% from $37.5 million recorded in Q1 2025.
  • Tango Therapeutics' 5-year Non-Current Deffered Revenue high stood at $116.6 million for Q3 2021, and its period low was $5.8 million during Q1 2021.
  • Moreover, its 5-year median value for Non-Current Deffered Revenue was $68.7 million (2023), whereas its average is $68.3 million.
  • Per our database at Business Quant, Tango Therapeutics' Non-Current Deffered Revenue skyrocketed by 189869.78% in 2021 and then tumbled by 4408.97% in 2025.
  • Over the past 5 years, Tango Therapeutics' Non-Current Deffered Revenue (Quarter) stood at $114.7 million in 2021, then fell by 19.73% to $92.1 million in 2022, then fell by 27.59% to $66.7 million in 2023, then tumbled by 32.87% to $44.8 million in 2024, then crashed by 32.01% to $30.4 million in 2025.
  • Its Non-Current Deffered Revenue stands at $30.4 million for Q2 2025, versus $37.5 million for Q1 2025 and $44.8 million for Q4 2024.